Coronavirus vaccine: China has not done any efficacy trials, Russia also has not done any efficacy trials. We are doing efficacy trials on 26,000 people in the third phase, he said

India on Sunday granted emergency approval to Bharat Biotech's COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine

The researchers said this demonstrates 94.1 per cent efficacy in preventing symptomatic COVID-19, adding that cases of severe disease occurred only in participants who received the placebo

The result is based on interim analysis of data from its Phase III clinical trial

Dalal Street witnessed gut-churning fluctuations, with the BSE Sensex swinging between historic losses and eye-popping gains, sometimes in the same session

Brazil is the first country to complete a late-stage trial of the vaccine, called CoronaVac, but a release of the results, first set for early December, has now been delayed three times

Spokespeople for Pfizer, Moderna and AstraZeneca have said that pork products are not part of their COVID-19 vaccines. But limited supply and preexisting deals worth millions of dollars with other companies means that some countries with large Muslim populations, such as Indonesia, will receive vaccines that have not yet been certified to be gelatin-free

Researchers said over half (51 per cent) of these doses will go to high income countries, which represent 14 per cent of the world's population

The deal comes in a week that AstraZeneca said it was conducting further research to confirm whether its COVID-19 vaccine could be 90% effective, potentially slowing its rollout, and as a rival shot from Pfizer was launched in Britain and approved for use in the United States

Two vaccine candidates stumbled on Friday in the race among researchers to combat Covid-19, even as the Pfizer jab nears approval in the US

India Stock Market Highlights Today: UltraTech Cement followed by Tata Steel, ONGC, IndusInd Bank, HDFC Bank, M&M, Infosys and Reliance Industries were among the top losers in the Sensex pack. On the other hand, Maruti, Nestle India, Titan and PowerGrid were among the gainers

In total, Britain has ordered 40 million doses of the Pfizer/BioNTech shot. As each person requires two doses, that is enough to vaccinate 20 million people in the country of 67 million

The company is currently conducting the last stage of clinical trials for its vaccine candidate in Brazil, Turkey and Indonesia and is among the frontrunners of China' s vaccine efforts

Confirmation of approval by National Health Regulatory Authority of Bahrain followed thorough analysis and review undertaken by authority of all available data

The RBI's revised projection stems from the recent boost in the economic revival -- both in rural as well as urban areas -- in many sectors

India Stock Market Highlights Today: During the session, Sensex touched a lifetime high of 45,148 and Nifty hit an all-time high of 13,280

After playing a critical role in transporting essentials and medical supplies during the lockdown, SpiceXpress, has come forth to take up the responsibility of seamlessly transporting the vaccine through a specialised service called Spice Pharma Pro

The move makes Britain one of the first countries to begin vaccinating its population as it tries to curb Europe's deadliest COVID-19 outbreak

Pfizer and BioNTech vaccine: The UK has already ordered 40 million doses of the Pfizer vaccine to vaccinate its 20 million population, of which around 10 million doses will be available soon

After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon